These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7772616)

  • 1. Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
    Ikeguchi K; Kuroda A
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):320-4. PubMed ID: 7772616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments and reply on Ikeguchi and Kuroda: Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
    Friedman JH; Ikeguchi K; Kuroda A
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):106-7. PubMed ID: 9063906
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic dilemma: psychosis and Parkinson's disease.
    Damecour CL; Turcotte JR
    Can J Psychiatry; 1995 Dec; 40(10):640-1. PubMed ID: 8681265
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease.
    Rosenthal SH; Fenton ML; Harnett DS
    Gen Hosp Psychiatry; 1992 Jul; 14(4):285-6. PubMed ID: 1505751
    [No Abstract]   [Full Text] [Related]  

  • 7. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.
    Mohr E; Mendis T; Hildebrand K; De Deyn PP
    Mov Disord; 2000 Nov; 15(6):1230-7. PubMed ID: 11104211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced psychotic symptoms in Parkinson's disease. Problems, management and dilemma.
    Kuzuhara S
    J Neurol; 2001 Sep; 248 Suppl 3():III28-31. PubMed ID: 11697685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone treatment of drug-related psychosis in patients with parkinsonism.
    Leopold NA
    Mov Disord; 2000 Mar; 15(2):301-4. PubMed ID: 10752580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 16. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine in the treatment of psychosis in Parkinson's disease.
    Friedman JH; Lannon MC
    Neurology; 1989 Sep; 39(9):1219-21. PubMed ID: 2771073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
    Barbato L; Monge A; Stocchi F; Nordera G
    Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
    Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.